Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2qry | TPS | Thiamine-binding periplasmic protein |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2qry | TPS | Thiamine-binding periplasmic protein | / | 1.000 | |
2xuf | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.499 | |
2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.487 | |
1ygk | RRC | Pyridoxal kinase | 2.7.1.35 | 0.483 | |
2xuj | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.483 | |
1gg5 | E09 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.482 | |
1w6j | R71 | Lanosterol synthase | 5.4.99.7 | 0.482 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.479 | |
1h60 | STR | Pentaerythritol tetranitrate reductase | / | 0.478 | |
2xuq | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.476 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.473 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.472 | |
2pb1 | NFG | Glucan 1,3-beta-glucosidase | / | 0.471 | |
3tfu | PL8 | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 2.6.1.62 | 0.471 | |
1q83 | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.470 | |
2ha6 | SCK | Acetylcholinesterase | 3.1.1.7 | 0.470 | |
2gyu | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.469 | |
4n65 | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.469 | |
1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.468 | |
2gyw | OBI | Acetylcholinesterase | 3.1.1.7 | 0.466 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.466 | |
2jf0 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.465 | |
2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.465 | |
1dx6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.462 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.460 | |
2ixk | TDO | dTDP-4-dehydrorhamnose 3,5-epimerase | 5.1.3.13 | 0.459 | |
3tn7 | NJP | Short-chain alcohol dehydrogenase | / | 0.459 | |
2wu4 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.457 | |
2xuh | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.456 | |
1yhj | R6C | Pyridoxal kinase | 2.7.1.35 | 0.455 | |
2aba | STR | Pentaerythritol tetranitrate reductase | / | 0.455 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.455 | |
1vft | DCS | Alanine racemase | / | 0.454 | |
2aou | CQA | Histamine N-methyltransferase | 2.1.1.8 | 0.454 | |
3ug8 | IMN | Aldo-keto reductase family 1 member C3 | / | 0.453 | |
4g5d | NDP | Prostaglandin F synthase | 1.1.1.188 | 0.453 | |
1w76 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
1x8l | OXR | Retinol dehydratase | / | 0.451 | |
2jgs | BTN | Avidin | / | 0.451 | |
3af2 | ACP | Pantothenate kinase | 2.7.1.33 | 0.451 | |
4cf6 | CBD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.450 | |
2xug | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.450 | |
3jsx | CC2 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.450 | |
1rkw | PNT | HTH-type transcriptional regulator QacR | / | 0.449 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.449 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.449 | |
1q84 | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.448 | |
2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.447 | |
2cmf | F11 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
4b7z | Q4Q | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
5jqh | CAU | Beta-2 adrenergic receptor | / | 0.447 | |
1xkq | NDP | Uncharacterized protein | / | 0.446 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
2xuk | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
5d6l | CAU | Beta-2 adrenergic receptor | / | 0.446 | |
1ut6 | A8N | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
2xui | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
3af0 | GDP | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
4hmn | 16J | Aldo-keto reductase family 1 member C3 | / | 0.445 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.444 | |
3bnm | SPJ | Polyamine oxidase FMS1 | / | 0.444 | |
4a16 | H34 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1ib0 | FAD | NADH-cytochrome b5 reductase 3 | 1.6.2.2 | 0.443 | |
1q23 | FUA | Chloramphenicol acetyltransferase | 2.3.1.28 | 0.443 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
3kr8 | XAV | Tankyrase-2 | 2.4.2.30 | 0.443 | |
4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.443 | |
3ny8 | JRZ | Beta-2 adrenergic receptor | / | 0.443 | |
2pnc | CLU | Primary amine oxidase, liver isozyme | / | 0.442 | |
4nv1 | 0FX | Formyl transferase | / | 0.442 | |
1tu8 | GTX | Glutathione S-transferase 2 | 2.5.1.18 | 0.441 | |
3ksq | Z96 | Protein farnesyltransferase subunit beta | 2.5.1.58 | 0.441 | |
3r8h | ZOM | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
3d4s | TIM | Beta-2 adrenergic receptor | / | 0.441 | |
1pj6 | FOL | Dimethylglycine oxidase | 1.5.3.10 | 0.440 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
3hf8 | ML0 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.440 | |
3hfb | ML4 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.440 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
4n9q | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.440 |